extra strength aspirin 325 mg

Generic: aspirin

Labeler: healthlife of usa llc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name extra strength aspirin 325 mg
Generic Name aspirin
Labeler healthlife of usa llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
HealthLife of USA LLC

Identifiers & Regulatory

Product NDC 69517-002
Product ID 69517-002_3e97c632-9a87-674e-e063-6294a90a72a6
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2025-09-12

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69517002
Hyphenated Format 69517-002

Supplemental Identifiers

RxCUI
212033
UPC
0369517002052
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name extra strength aspirin 325 mg (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 500 TABLET, FILM COATED in 1 BOTTLE (69517-002-05)
source: ndc

Packages (1)

69517-002-05 500 TABLET, FILM COATED in 1 BOTTLE (69517-002-05)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

Extra Strength Aspirin 325 mg ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3e97c632-9a87-674e-e063-6294a90a72a6", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0369517002052"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["1d4fbc45-ef89-45ab-bc6d-41f30b468ac7"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["HealthLife of USA LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (69517-002-05)", "package_ndc": "69517-002-05", "marketing_start_date": "20250912"}], "brand_name": "Extra Strength Aspirin 325 mg", "product_id": "69517-002_3e97c632-9a87-674e-e063-6294a90a72a6", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "69517-002", "generic_name": "Aspirin", "labeler_name": "HealthLife of USA LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Extra Strength Aspirin 325 mg", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250912", "listing_expiration_date": "20261231"}